Lv6
2520 积分 2022-08-08 加入
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
9天前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
17天前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
17天前
已完结
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
17天前
已完结
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
22天前
已完结
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
22天前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
1个月前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
1个月前
已完结
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study
1个月前
已完结
泰它西普治疗IgA肾病临床实践专家指导意见（2026版）
1个月前
已完结
皖公网安备34019202002308
